HeraMED Limited (ASX:HMD)
0.0480
+0.0010 (2.13%)
Apr 7, 2026, 4:10 PM AEST
HeraMED Market Cap
HeraMED has a market cap or net worth of 55.44 million as of April 7, 2026. Its market cap has increased by 233.24% in one year.
Market Cap
55.44M
Enterprise Value
54.07M
Revenue
431.61K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since December 12, 2018, HeraMED's market cap has increased from 15.76M to 55.44M, an increase of 251.88%. That is a compound annual growth rate of 18.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 55.44M | 43.90% |
| Dec 31, 2025 | 38.53M | 120.00% |
| Dec 31, 2024 | 17.51M | 127.12% |
| Dec 29, 2023 | 7.71M | -74.58% |
| Dec 30, 2022 | 30.33M | -32.86% |
| Dec 31, 2021 | 45.18M | 173.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Epiminder | 133.60M |
| SomnoMed | 129.26M |
| Cleo Diagnostics | 75.96M |
| Compumedics | 54.93M |
| CleanSpace Holdings | 37.09M |
| Micro-X | 37.03M |
| Nova Eye Medical | 35.61M |
| ImpediMed | 31.60M |